Methods Of Treatment For Esophageal Inflammation

Patent No. EP2585075 (titled "Methods Of Treatment For Esophageal Inflammation") was filed by Meritage Pharma on Jun 24, 2011. The application was issued on Sep 22, 2021.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
DR FALK PHARMA	May 4, 2022	LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Dec 9, 2022
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Dec 9, 2022
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Dec 6, 2022
Termination of the opposition proceedings with revocation of patent
Sep 7, 2022
Advice of delivery
Aug 30, 2022
Advice of delivery
Aug 25, 2022
Decision revoking the European patent
Aug 25, 2022
Decision revoking the European patent
Aug 25, 2022
Transmittal of decision / summons - opposition
Aug 25, 2022
Transmittal of decision / summons - opposition
Aug 19, 2022
(Electronic) Receipt
Aug 19, 2022
Letter accompanying subsequently filed items
Aug 19, 2022
Request for revocation of patent
Jun 2, 2022
Communication of a notice of opposition and request to file observations
Jun 2, 2022
Notice of further oppositions to opponent(s)
May 10, 2022
Communication of a notice of opposition - first information to patent proprietor
May 4, 2022
(Electronic) Receipt
May 4, 2022
Citation in opposition procedure - 001
May 4, 2022
Citation in opposition procedure - 002
May 4, 2022
Citation in opposition procedure - 003
May 4, 2022
Citation in opposition procedure - 004
May 4, 2022
Citation in opposition procedure - 005
May 4, 2022
Citation in opposition procedure - 006
May 4, 2022
Citation in opposition procedure - 007
May 4, 2022
Citation in opposition procedure - 008
May 4, 2022
Citation in opposition procedure - 009
May 4, 2022
Citation in opposition procedure - 009
May 4, 2022
Citation in opposition procedure - 010
May 4, 2022
Citation in opposition procedure - 011
May 4, 2022
Citation in opposition procedure - 012
May 4, 2022
Citation in opposition procedure - 013
May 4, 2022
Citation in opposition procedure - 014
May 4, 2022
Consolidated list of cited opposition documents
May 4, 2022
Notice of opposition
May 4, 2022
Notice of opposition
Aug 31, 2021
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Aug 13, 2021
Communication of amended entries concerning the representative
Aug 5, 2021
Letter accompanying subsequently filed items
Aug 5, 2021
Submission concerning change of applicant's representative
Jul 28, 2021
Communication of the registration of a transfer or change of name and/or address
Jul 22, 2021
Decision to grant a European patent
Jul 20, 2021
(Electronic) Receipt
Jul 20, 2021
Annexes in respect of a client data request
Jul 20, 2021
Annexes in respect of a client data request
Jul 20, 2021
Letter accompanying subsequently filed items
Jul 20, 2021
Submission concerning a transfer of rights (applicant)
Jul 9, 2021
(Electronic) Receipt
Jul 9, 2021
Filing of the translations of the claims
Jul 9, 2021
French translation of claims
Jul 9, 2021
German translation of the claims
Jul 9, 2021
Letter accompanying subsequently filed items
Mar 2, 2021
Bibliographic data of the European patent application
Mar 2, 2021
Communication about intention to grant a European patent
Mar 2, 2021
Intention to grant (signatures)
Mar 2, 2021
Text intended for grant (clean copy)
Mar 2, 2021
Text intended for grant (version for approval)
Feb 4, 2021
(Electronic) Receipt
Feb 4, 2021
Amended description with annotations
Feb 4, 2021
Description
Feb 4, 2021
Letter accompanying subsequently filed items
Feb 4, 2021
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Oct 6, 2020
Bibliographic data of the European patent application
Oct 6, 2020
Communication about intention to grant a European patent
Oct 6, 2020
Intention to grant (signatures)
Oct 6, 2020
Text intended for grant (clean copy)
Oct 6, 2020
Text intended for grant (version for approval)
Sep 1, 2020
Notification concerning the date of oral proceedings
Aug 5, 2020
(Electronic) Receipt
Aug 5, 2020
Amended claims with annotations
Aug 5, 2020
Amended description with annotations
Aug 5, 2020
Claims
Aug 5, 2020
Description
Aug 5, 2020
Letter accompanying subsequently filed items
Aug 5, 2020
Written submission in preparation to/during oral proceedings
Jul 24, 2020
(Electronic) Receipt
Jul 24, 2020
Letter accompanying subsequently filed items
Jul 24, 2020
Written submission in preparation to/during oral proceedings
May 7, 2020
Annex to the communication
May 7, 2020
Summons to attend oral proceedings
Apr 30, 2020
Notification concerning the date of oral proceedings
Apr 8, 2020
(Electronic) Receipt
Apr 8, 2020
Letter accompanying subsequently filed items
Apr 8, 2020
Written submission in preparation to/during oral proceedings
Apr 6, 2020
Notification concerning the date of oral proceedings
Mar 25, 2020
(Electronic) Receipt
Mar 25, 2020
Letter accompanying subsequently filed items
Mar 25, 2020
Oral proceedings: Request for postponement
Mar 19, 2020
Annex to the communication
Mar 19, 2020
Notification concerning the date of oral proceedings
Jan 30, 2020
(Electronic) Receipt
Jan 30, 2020
Citation for the examination procedure
Jan 30, 2020
Letter accompanying subsequently filed items
Jan 30, 2020
Oral proceedings: Request for postponement
Dec 17, 2019
Annex to the communication
Dec 17, 2019
Summons to attend oral proceedings
Dec 19, 2018
(Electronic) Receipt
Dec 19, 2018
Amended claims with annotations
Dec 19, 2018
Claims
Dec 19, 2018
Letter accompanying subsequently filed items
Dec 19, 2018
Reply to communication from the Examining Division
Aug 9, 2018
Annex to the communication
Aug 9, 2018
Communication from the Examining Division
Feb 22, 2018
(Electronic) Receipt
Feb 22, 2018
Amended claims with annotations
Feb 22, 2018
Claims
Feb 22, 2018
Letter accompanying subsequently filed items
Feb 22, 2018
Reply to communication from the Examining Division
Oct 13, 2017
Annex to the communication
Oct 13, 2017
Communication from the Examining Division
Oct 6, 2017
Examination started
Jul 31, 2017
Communication of amended entries concerning the representative
Jul 24, 2017
Submission concerning change of applicant's representative
Jul 14, 2017
Notification regarding date of start of examination with possibility to withdraw
May 23, 2014
(Electronic) Receipt
May 23, 2014
Amended claims filed after receipt of (European) search report
May 23, 2014
Amended claims with annotations
May 23, 2014
Amendments received before examination
May 23, 2014
Letter accompanying subsequently filed items
Nov 15, 2013
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Oct 29, 2013
Communication regarding the transmission of the European search report
Oct 29, 2013
European search opinion
Oct 29, 2013
Supplementary European search report
Jun 26, 2013
CDS Clean up - amended data concerning the representative for the applicant
Jun 6, 2013
Submission concerning representation
Apr 4, 2013
Notification on forthcoming publication of bibliographic data
Mar 1, 2013
Communication regarding possible amendment of the application/payment of claims fee
Feb 27, 2013
Communication to designated inventor
Feb 27, 2013
Communication to designated inventor
Jan 24, 2013
(Electronic) Receipt
Jan 24, 2013
Amended claims filed after receipt of (European) search report
Jan 24, 2013
Amendments received before examination
Jan 24, 2013
Request for entry into the European phase
Jan 16, 2013
Copy of the international preliminary report on patentability
Nov 5, 2012
Information on entry into European phase
Apr 5, 2012
Copy of the international search report
Apr 5, 2012
International publication of the international search report
Jan 17, 2012
Priority document (electronically transmitted)
Jan 17, 2012
Priority document (electronically transmitted)
Jan 17, 2012
Priority document (electronically transmitted)
Jan 17, 2012
Priority document (electronically transmitted)
Dec 29, 2011
Published international application - A2

EP2585075

MERITAGE PHARMA

Application Number: EP11799004A
Filing Date: Jun 24, 2011
Status: Revoked; Dec 9, 2022
Publication Date: Sep 22, 2021
External Links: Slate, Register , Google Patents

IP Verse

Methods Of Treatment For Esophageal Inflammation

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2585075